elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope - LARVOL DELTA

A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine (clinicaltrials.gov) - P2 | N=400 | Recruiting | Sponsor: Kallyope Inc. | Not yet recruiting ➔ Recruiting

Enrollment open • CNS Disorders • Migraine • Pain

A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine (clinicaltrials.gov) - P2 | N=400 | Not yet recruiting | Sponsor: Kallyope Inc.

New P2 trial • CNS Disorders • Migraine • Pain

Exploratory Study of MT-8554 in Subjects With Painful Diabetic Peripheral Neuropathy (clinicaltrials.gov) - P2 | N=156 | Completed | Sponsor: Mitsubishi Tanabe Pharma Corporation | Active, not recruiting ➔ Completed | Trial completion date: Jun 2023 ➔ Nov 2022 | Trial primary completion date: Mar 2023 ➔ Nov 2022

Trial completion • Trial completion date • Trial primary completion date • Diabetic Neuropathy • Pain • Peripheral Neuropathic Pain

Exploratory Study of MT-8554 in Subjects With Painful Diabetic Peripheral Neuropathy (clinicaltrials.gov) - P2 | N=144 | Active, not recruiting | Sponsor: Mitsubishi Tanabe Pharma Corporation | Recruiting ➔ Active, not recruiting

Enrollment closed • Diabetic Neuropathy • Pain • Peripheral Neuropathic Pain

Exploratory Study of MT-8554 in Subjects With Painful Diabetic Peripheral Neuropathy (clinicaltrials.gov) - P2; N=144; Recruiting; Sponsor: Mitsubishi Tanabe Pharma Corporation; Not yet recruiting ➔ Recruiting

Clinical • Enrollment open • Diabetic Neuropathy • Pain • Peripheral Neuropathic Pain

Exploratory Study of MT-8554 in Subjects With Painful Diabetic Peripheral Neuropathy (clinicaltrials.gov) - P2; N=144; Not yet recruiting; Sponsor: Mitsubishi Tanabe Pharma Corporation

Clinical • New P2 trial • Diabetic Neuropathy • Pain • Peripheral Neuropathic Pain

Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms (clinicaltrials.gov) - P2; N=190; Completed; Sponsor: Mitsubishi Tanabe Pharma Development America, Inc.; Active, not recruiting ➔ Completed; N=100 ➔ 190; Trial completion date: Mar 2020 ➔ Nov 2019

Clinical • Enrollment change • Trial completion • Trial completion date

Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms (clinicaltrials.gov) - P2; N=100; Active, not recruiting; Sponsor: Mitsubishi Tanabe Pharma Development America, Inc.; Trial completion date: Jul 2019 ➔ Mar 2020; Trial primary completion date: Apr 2019 ➔ Dec 2019

Clinical • Trial completion date • Trial primary completion date